May 2026 LTS Lohmann Therapie-Systeme AG expanded its research and development capabilities for advanced drug delivery technologies, including osmotic-controlled release systems, to support the development of long-acting pharmaceutical products.
March 2026 Evonik Industries introduced new pharmaceutical excipients designed to enhance controlled- and osmotic-release oral drug formulations, expanding its portfolio for advanced drug delivery applications.
December 2025 Colorcon launched an enhanced range of functional excipients for osmotic pump tablet formulations, enabling improved drug release control and formulation flexibility for pharmaceutical manufacturers.
September 2025 Almac Group expanded its pharmaceutical development and manufacturing services for modified-release dosage forms, including osmotic-controlled drug delivery technologies, by increasing formulation development capacity.